Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Malcolm Mason

Showing results (21-30 of 71) with videos related to

Pageof 8
Sort By:
International Journal of Oncology|March 6, 2017
Dual roles of protein tyrosine phosphatase kappa in coordinating angiogenesis induced by pro-angiogenic factorsPing-Hui Sun, Gang Chen, Malcolm Mason, et al.
European Journal of Cancer Care|September 3, 2019
Patients' and partners' views of care and treatment provided for metastatic castrate-resistant prostate cancer in the UKSusan Catt, Lucy Matthews, Shirley May, et al.
Journal of Clinical Pathology|May 4, 2018
Contemporary prostate biopsy reporting: insights from a survey of clinicians' use of pathology dataMurali Varma, Krishna Narahari, Malcolm Mason, et al.
Bioorganic & Medicinal Chemistry|April 6, 2005
Anti-cancer ProTides: tuning the activity of BVDU phosphoramidates related to thymectacinChristopher McGuigan, Jean-Christophe Thiery, Felice Daverio, et al.
The Cochrane Database of Systematic Reviews|January 20, 2012
Intravesical gemcitabine for non-muscle invasive bladder cancerGabriel Jones, Anne Cleves, Timothy J Wilt, et al.
The Lancet. Oncology|February 8, 2018
Adoption of robotic surgery: driven by market competition or a desire to improve patient care? - Authors' replyAjay Aggarwal, Daniel Lewis, Malcolm Mason, et al.
European Urology Oncology|July 17, 2019
Imaging and T Category for Prostate Cancer in the 8th Edition of the Union for International Cancer Control TNM ClassificationHenk van der Poel, Theo van der Kwast, Katja Aben, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 10, 2005
A randomised trial of accelerated radiotherapy for localised invasive bladder cancerAlan Horwich, David Dearnaley, Robert Huddart, et al.
The Lancet. Oncology|October 8, 2017
Effect of patient choice and hospital competition on service configuration and technology adoption within cancer surgery: a national, population-based studyAjay Aggarwal, Daniel Lewis, Malcolm Mason, et al.
The Cochrane Database of Systematic Reviews|November 7, 2015
WITHDRAWN: Intravesical Bacillus Calmette-Guérin versus mitomycin C for Ta and T I bladder cancerMike Shelley, J B Court, Howard G Kynaston, et al.
Pageof 8

Showing results (21-30 of 71) with videos related to

Sort By:
Pageof 8
International Journal of Oncology|March 6, 2017
Dual roles of protein tyrosine phosphatase kappa in coordinating angiogenesis induced by pro-angiogenic factorsPing-Hui Sun, Gang Chen, Malcolm Mason, et al.
European Journal of Cancer Care|September 3, 2019
Patients' and partners' views of care and treatment provided for metastatic castrate-resistant prostate cancer in the UKSusan Catt, Lucy Matthews, Shirley May, et al.
Journal of Clinical Pathology|May 4, 2018
Contemporary prostate biopsy reporting: insights from a survey of clinicians' use of pathology dataMurali Varma, Krishna Narahari, Malcolm Mason, et al.
Bioorganic & Medicinal Chemistry|April 6, 2005
Anti-cancer ProTides: tuning the activity of BVDU phosphoramidates related to thymectacinChristopher McGuigan, Jean-Christophe Thiery, Felice Daverio, et al.
The Cochrane Database of Systematic Reviews|January 20, 2012
Intravesical gemcitabine for non-muscle invasive bladder cancerGabriel Jones, Anne Cleves, Timothy J Wilt, et al.
The Lancet. Oncology|February 8, 2018
Adoption of robotic surgery: driven by market competition or a desire to improve patient care? - Authors' replyAjay Aggarwal, Daniel Lewis, Malcolm Mason, et al.
European Urology Oncology|July 17, 2019
Imaging and T Category for Prostate Cancer in the 8th Edition of the Union for International Cancer Control TNM ClassificationHenk van der Poel, Theo van der Kwast, Katja Aben, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 10, 2005
A randomised trial of accelerated radiotherapy for localised invasive bladder cancerAlan Horwich, David Dearnaley, Robert Huddart, et al.
The Lancet. Oncology|October 8, 2017
Effect of patient choice and hospital competition on service configuration and technology adoption within cancer surgery: a national, population-based studyAjay Aggarwal, Daniel Lewis, Malcolm Mason, et al.
The Cochrane Database of Systematic Reviews|November 7, 2015
WITHDRAWN: Intravesical Bacillus Calmette-Guérin versus mitomycin C for Ta and T I bladder cancerMike Shelley, J B Court, Howard G Kynaston, et al.
Pageof 8